Loading reports catalog...
Loading reports catalog...
Access deep-dive research across global industry sectors to empower your strategic decision-making with data-driven insights.
Explore our comprehensive collection of healthcare market research reports, offering in-depth insights into the rapidly evolving global healthcare ecosystem. Our detailed analysis covers various segments, providing crucial medical device market analysis and identifying emerging trends across pharmaceuticals, biotechnology, and healthcare IT. As part of our specialized offerings, we provide granular data on niche sectors like the sterilization equipment market, ensuring industry leaders have the actionable intelligence needed for strategic planning and competitive benchmarking. Our reports deliver precise market sizing, growth forecasts, and competitive landscape assessments to guide your business decisions in the dynamic healthcare industry.
Showing 126 Results
The global artificial retina market was evaluated at USD 1,179.71 million in 2025 and is expected to expand at a CAGR of 24.1% from USD 1,444.20 million in 2026 to USD 10,058.57 million in 2035. The robust market expansion is fueled by increasing demand for vision-recovery options for patients with severe retinal degenerative conditions, especially retinitis pigmentosa and advanced age-related macular degeneration. Improvements in retinal implants, photovoltaic devices, microelectronics, wireless energy transfer, and dense electrode arrays are enhancing the prospects of artificial vision technologies.
The global artificial disc replacement market was valued at USD 671.70 million in 2025 and is expected to expand at a CAGR of 8.2% from USD 715.36 million in 2026 to USD 1,459.62 million in 2035. The strong market growth is propelled by the increasing prevalence of degenerative disc disease, rising burden of chronic neck and back pain, growing preference for motion-preserving alternatives to spinal fusion, and advancements in implant materials and surgical techniques.
The U.S. dental cement market was evaluated at USD 812.69 million in 2025 and is projected to grow at a CAGR of 5.3% from USD 849.02 million in 2026 to USD 1,353.57 million in 2035. The market growth is primarily driven by the increasing adoption of restorative dental procedures, including crowns, bridges, inlays, and implant-supported prosthetics. Additionally, the growing utilisation of CAD/CAM-based dental restorations, rising demand for durable and aesthetically appealing luting materials, ongoing innovations in bioactive and adhesive cement formulations, and expanding access to preventive and restorative oral healthcare services are supporting the growth of the U.S. dental cement market.
The U.S. orthopedic devices market was evaluated at USD 25.5 billion in 2025 and is projected to grow at a CAGR of 4.3% from USD 26.3 billion in 2026 to USD 38.5 billion in 2035. The market growth is primarily driven by the increasing prevalence of musculoskeletal disorders and degenerative bone conditions requiring surgical intervention. Additionally, the growing geriatric population susceptible to joint and spine-related ailments, rising incidence of sports and trauma injuries, expanding adoption of minimally invasive orthopedic procedures, and ongoing technological innovations in implants and robotic-assisted orthopedic systems are supporting the growth of the U.S. orthopedic devices market.
The U.S. facial implants market was evaluated at USD 933.47 million in 2025 and is projected to grow at a CAGR of 6.9% from USD 992.00 million in 2026 to USD 1803.83 million in 2035. The market growth is primarily driven by the increasing preference for facial contouring and enhancement procedures aimed at improving facial symmetry and definition. Additionally, the rising volume of reconstructive surgeries following trauma and congenital deformities, continuous advancements in implant materials and customisation technologies, and the availability of sophisticated healthcare infrastructure are supporting the growth of the U.S. facial implants market.
The U.S. interventional cardiology market size was estimated at USD 4.45 billion in 2025. The market is expected to grow at a CAGR of 5.9% from USD 4.69 billion in 2026 to USD 7.83 billion in 2035. The market expansion is supported by the wider deployment of catheterisation laboratories, growing utilisation of drug-eluting balloons, increasing use of intracoronary imaging and physiological assessment, advances in lesion-preparation technologies, and the expanding availability of same-day interventional care pathways.
Stay informed with updates on related market reports and key industry topics.